Geneva, June 22 -- International Clinical Trials Registry received information related to the study (ChiCTR2600126564) titled 'To evaluate the efficacy and safety of nintedanib in combination with glucocorticoids compared with glucocorticoids alone in the treatment of pneumonitis (RP): a randomized controlled multicenter clinical trial' on June 11.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: The Affiliated Cancer Hospital of Shandong First Medical University

Condition: Lung cancer

Intervention: Experimental group:Nintedanib in combination with glucocorticoids

Recruitment Status: Recruiting

Phase: 4

Date of First Enrollment: 2025-12-16

Target Sample Size: Experimental group:72;Control group:72; ...